Bladder Cancer Coverage from Every Angle

Published Medical Literature

Identifying Key Genes in Bladder Cancer May Improve Outcomes With Immunotherapy
DNA Repair Biomarkers as Prognostic Indicators in Patients With Bladder Cancer
Researchers Explore the Potential Prognostic Role of SIRT4 in Bladder Cancer
Do 5α-Reductase Inhibitors Have Protective Benefits Against Bladder Cancer Progression?
Synergy Between FGFR and HDAC Inhibitors in FGFR3-Driven Bladder Cancer
Chemotherapy Selection Under Study in Intermediate-Risk, Non–Muscle Invasive Bladder Cancer
Comparable Outcomes With Partial Versus Radical Cystectomy in Muscle-Invasive Bladder Cancer?
Prognostic Risk Score Model for Bladder Tumors Based on Immunotherapy-Related Long Noncoding RNAs
BCG Vaccine Therapy and Risk of Dementia in Patients With Non–Muscle-Invasive Bladder Cancer
Strategies for Reversing Treatment Exhaustion in Immunologically Nonresponsive Urothelial Carcinoma
Study Examines Potential Link Between Agent Orange and Bladder Cancer in U.S. Veterans
Bladder-Sparing Regimen Under Study in T1 High-Grade or T2 Bladder Cancer
Novel Urinary Biomarkers for Bladder Cancer Diagnosis and Staging Under Study
The Cost of Treating Non–Muscle-Invasive Bladder Cancer: From a German Claims Analysis
Does History of Malignancy Impact Oncologic Outcomes in Urothelial Carcinoma?
ABCF1 Expression and Prognosis in Patients With Bladder Cancer
Prognosis Signature Based on Copper-Induced Cell Death Under Study in Bladder Cancer
Using RNA-Sequencing Data to Establish a Prognostic Model for Bladder Cancer
Destabilizing a Protein May Help to Inhibit Bladder Cancer Cell Proliferation
How Clinically Useful Is Machine Learning to Identify Residual Disease in Patients With Bladder Cancer?
Nivolumab Plus Ipilimumab: Tailored Immunotherapy Strategy for Metastatic Urothelial Cancer
Efflux Transporters and Cisplatin Toxicity and Resistance in Urinary Bladder Cancer
Is a Double-Blind Study Comparing Surgical Techniques in Bladder Cancer Feasible?
Can the Mark Cuban Cost Plus Drug Company Model Reduce Costs for Patients With Urologic Diseases?
Intravesical Drug-Delivery System Plus PD-1 Inhibitor Under Study in Urothelial Bladder Carcinoma
Adjuvant Nivolumab for High-Risk Urothelial Cancer: Focus on Disease-Free Survival From CheckMate 274
Could a HOTAIR-Related RNA Signaling Pathway Be the Key to Cachexia Relief?
Use of Nomograms to Assess Risk Factors and Prognosis in Patients With Bladder Cancer
Can a Novel Approach to Transurethral Resection Reduce Recurrence of Bladder Cancer?
Does NEAT1 Play a Tumorigenic Role in Bladder Cancer?
Rare Case of Condyloma Acuminatum in the Bladder, Surrounding Areas
Does Nab-paclitaxel Plus Pembrolizumab Have a Place in the Treatment Paradigm of Advanced Urothelial Cancer?
Targeted PD-L1 Therapy for Bladder Cancer: View From the Middle East
Can an IL-15 Superagonist Induce a Response in Patients Who Do Not Respond to BCG?
Laser Treatment for Non–Muscle-Invasive Bladder Cancer: From a Single Center in China
Chemoresection With Mitomycin for Recurrent Non–Muscle-Invasive Bladder Cancer
Novel Machine Learning Approach to Medical Decision-Making in Bladder Cancer
Genomic Analysis May Guide Treatment Selections in Metastatic Urothelial Cancer
Chinese Research Team Identifies Potential Biomarker of Early-Stage Bladder Cancer
Neoadjuvant Chemotherapy for Bladder Cancer: Focus on Immune Cells in the Tumor Microenvironment
Pregnancy After Sexuality-Preserving Cystectomy for Bladder Cancer: Case Report
Phase III Subgroup Analysis of Enfortumab Vedotin in Japanese Patients With Advanced Urothelial Carcinoma
Detecting Bladder Cancer in Patients With Hematuria: Novel Urine DNA Methylation Test Under Study
Prognostic Marker in Bladder Cancer May Be Linked to Metabolism and Drug Resistance
Upper Tract Urothelial Cancer: Prognostic Relevance of the Site of Metastases
Tumor Mutational Burden as a First-Line Treatment Decision Aid in Cisplatin-Unfit Patients With Urothelial Carcinoma
Improving Preoperative Treatment Plans in Bladder Cancer: Focus on Cystoscopic Parameters
Bladder Cancers With a Glandular Phenotype: Comparing Outcomes and Genomic Alteration Profiles
Case Report Focuses on Elevated HCG Level and Risk of Urothelial Carcinoma
Risk Factors for Early Recurrence After Transurethral Resection of Bladder Cancer
Therapeutic Potential of Adding the Flavonoid Cannflavin A to Other Agents in Bladder Cancer
Is Neoadjuvant Standard of Care for Muscle-Invasive Bladder Cancer Appropriate for Older Patients?
Using Multiomic Sequencing to Predict Progression of Non–Muscle-Invasive Bladder Cancer
How Accurate Are Immune-Related Prognostic Signature Scores in Predicting Outcomes in Bladder Cancer?
Antitumor Effects of Metformin Under Study in Bladder Cancer
Gene Identified as Prognostic Biomarker—and Potential Target—in Bladder Cancer
Using C-Reactive Protein Kinetics to Predict Immunotherapy Response in Metastatic Urothelial Carcinoma
Expectations of Care Planning for Older Adults With Advanced Bladder Cancer
Does SNCA Expression Impact Survival Outcomes in Bladder Cancer?
Radical Cystectomy for Bladder Cancer: Comparison of Surgical Techniques From Sweden
Case Report: Transurethral Resection for Osteosarcoma of the Bladder
Can Oxidative Stress–Related Genes Predict Outcomes for Patients With Bladder Cancer?
Update on Managing Bladder Cancer: An Evolving Landscape
Alternatives to Radical Cystectomy for Muscle-Invasive Urothelial Carcinoma: Clinical Considerations
TRIM38/GLUT1 Axis May Promote Bladder Cancer Tumorigenesis
Adding Nintedanib to Neoadjuvant Chemotherapy for Locally Advanced Bladder Cancer
Evaluating the Risk of BK Polyomavirus Infection During Childhood and Future Bladder Cancer
Seven-Gene Signature Risk Score: Predictive of Prognosis in Bladder Cancer?
Study Finds Disproportionate Racial and Ethnic Representation in Clinical Trials for Bladder Carcinoma
Can Tumor Morphology Predict Depth of Invasion in Bladder Cancer?
Early-Phase Study of Infigratinib Supports Further Work in Metastatic Urothelial Carcinoma
Predicting Recurrence in Bladder Cancer: Focus on Immune Profiles, DNA Methylation Alterations
Alternative to Intravesical Chemotherapy Under Study in Non–Muscle-Invasive Bladder Cancer
The Impact of Neoadjuvant Immunotherapy in Muscle-Invasive Bladder Cancer
Use of Cabozantinib Plus Nivolumab After Immunotherapy in Metastatic Urothelial Carcinoma
Is There a Link Between Bladder Cancer and Human Papillomavirus?
Long Non-Coding RNA: Potential Therapeutic Target in Bladder Cancer?
Predicting Prognosis in Bladder Cancer: Focus on Unfolded Protein Response–Related Gene Signature
Use of Toripalimab in the Second-Line Setting for Advanced Urothelial Carcinoma
Newly Developed and Validated Prognostic Signature for Patients With Bladder Cancer
Effect of Smoking-Related Lung Disease on Bladder Urothelial Carcinoma Survival
Pancreaticoduodenectomy for Metastasized Bladder Cancer: Case Report
Preclinical Study of Tumor Microenvironment in Bladder Cancer Offers Clues to Causes of Chemoresistance
Five-Gene Score Model Under Study in Predicting Outcomes in Bladder Cancer
Evaluating Risk-Aligned Bladder Cancer Surveillance Practices
Metastatic Urothelial Cancer: Does Prior Treatment Hinder the Effectiveness of Pembrolizumab Therapy?
Cisplatin Versus Carboplatin: Overall Survival in Dutch Cohort Study of Metastatic Bladder Cancer
Treatment of Bladder Cancer After Platinum and PD-1/L1 Inhibitor Therapy: Real-World Outcomes
Rare Combination of Fibroepithelial Polyp and Kidney Cancer in a Patient With Bladder Cancer
Can Novel ATR Inhibitor Augment Activity of Chemotherapy in Advanced Urothelial Carcinoma?
Low-Grade Bladder Cancer: Can Mitomycin-Based Chemoablation Reduce the Need for Surgery?
Can Urothelial Bladder Carcinoma Cause Chronic Knee Problems?
Case Report: Older Woman With Metastatic Bladder Cancer Responds to Pembrolizumab
Laser Versus Electrical En Bloc Resection of Bladder Tumors
CheckMate 274: Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma
Are Lebanese and Jordanian Populations at Higher Risk for Bladder Cancer?
Enfortumab Vedotin-ejfv Under Study in Cisplatin-Ineligible Urothelial Carcinoma
Rare Case of Bladder Metastasis of Kidney Cancer: Potential Role of Genomic Analysis
Bacillus Calmette-Guérin Therapy for Bladder Cancer and Likelihood of COVID-19 Infection
Feasibility Study in Upper Tract Urothelial Cancer: Neoadjuvant Pembrolizumab Before Surgery
Impact of COVID-19 on Cystoscopic Surveillance for Non–Muscle-Invasive Bladder Cancer
Treatment Patterns and Outcomes in Muscle-Invasive Bladder Cancer
Combination Therapy for Metastatic Urothelial Bladder Carcinoma With FGFR3 Mutation: A Case Study
Identifying Bladder Cancer Subtypes by Metabolic Characteristics: Therapeutic Implications
STAG2 Immunostaining: Potential Biomarker in Predicting Bladder Cancer Outcomes?
Adjuvant Nivolumab for Patients With High-Risk Muscle-Invasive Urothelial Carcinoma
Camrelizumab Treatment in Upper Tract Urothelial Carcinoma: Case Report
Hypoxia-Related Gene Signature: An Independent Clinical Predictor in Bladder Cancer?
Mixed Results With Rucaparib in ATLAS Trial in Metastatic Urothelial Cancer
CALGB 90601: Combination Gemcitabine and Cisplatin With Bevacizumab in Urothelial Carcinoma
Resistant Urothelial Carcinoma: Organ-Specific Response to Pembrolizumab
The Hormone Ghrelin: Potential Prognostic Predictor in Muscle-Invasive Bladder Cancer?
Rare Complication of Intravesical BCG Therapy for Bladder Cancer: Case Report
Is Dietary Acrylamide Intake Associated With the Development of Bladder Cancer?
Does a Family History of Any Cancer Increase the Risk for Bladder Cancer?
Do Men and Women With Urinary Bladder Cancer Respond Differently to BCG Immunotherapy?
Can Treatment-Specific COXEN Scores Predict Responses to Neoadjuvant Chemotherapy for Bladder Cancer?
Diagnostic Utility of Serum N‐glycan Profiles in Urothelial Carcinomas
TP53-Mutated Bladder Cancer: Identifying Patients Who May Benefit From Immunotherapy
Does Use of Aspirin Improve Outcomes in Older Adults With Bladder Cancer?
Prescription of Psychotropic Drugs in Older Patients With Bladder Cancer
Low-Dose BCG Tokyo Strain for Non–Muscle-Invasive Bladder Cancer
Unleashing the Therapeutic Potential of Natural Compounds Against Bladder Cancer
Systemic Treatment of Metastatic Bladder Cancer: Dutch Study of Current Clinical Practice
Radical Cystectomy Versus BCG Treatment for High-Risk Bladder Cancer
Novel Prognostic Biomarker for Bladder Cancer Investigated
Immunotherapy for Urothelial Cancer: Balancing Benefits and Risks
Preferred Treatment for Invasive Bladder Cancer: Intravesical Immunotherapy or Radical Cystectomy?
Measures of Tumor Heterogeneity: Useful Biomarkers of Bladder Carcinoma?
Study Identifies Potential Biomarker of Bladder Carcinoma Recurrence
Impact of Preoperative Positive Voided Urine Cytology on Prognosis in Urothelial Cancer
Intravesical Nadofaragene Firadenovec in Non–Muscle Invasive Bladder Cancer
Ramucirumab Plus Docetaxel in Urothelial Carcinoma: Patient-Reported Outcomes From RANGE Trial
Pelvic Radiotherapy Combined With Chemotherapy in Metastatic Urothelial Cancer
Predicting Risk of Recurrence in Nonmuscle‐Invasive Bladder Cancer
Preoperative Chemotherapy for High-Grade Upper Tract Urothelial Carcinoma
Nab-paclitaxel Versus Paclitaxel in Metastatic Urothelial Cancer
Surveillance Strategy for Patients With Upper Tract Urothelial Carcinoma
Dose-Dense Chemotherapy for Muscle-Invasive Bladder Cancer: Phase III Trial Toxicity Update
Case Study: Neoadjuvant Pembrolizumab in Chemoresistant Urothelial Carcinoma
Targeting Bladder Carcinoma in Situ With Novel Gene Therapy
After Surgery for Upper Urinary Tract Urothelial Carcinoma: Surveillance or Chemotherapy?
Potential Genomic Predictors of Outcomes in High-Grade T1 Bladder Cancer
DANUBE Trial: Survival Outcomes With Durvalumab in Advanced Urothelial Carcinoma
Combination Regimen Under Study in Metastatic Urothelial Carcinoma
Update on Managing Non–Muscle-Invasive Bladder Cancer
Can Leukocyte Telomere Length Predict Bladder Cancer Risk?
Bladder Urothelial Carcinoma: Is Age Related to Risk of Lymph Node Metastasis?
Early Results With Buparlisib in Treatment of Metastatic Urothelial Carcinoma
Testicular Tuberculosis: Case Study of Rare Complication of Urothelial Cancer Treatment
Perioperative Chemotherapy for High‐Risk Upper Tract Urothelial Carcinoma
Early Findings With Magnetic Resonance–Guided Radiotherapy for Bladder Cancer
Researchers Identify Potential of Natural Coumarin Derivative in Treatment of Bladder Cancer

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.